Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EMG1 |
| Upstream (Parents) |
|---|
| (<<) ANTXR2 → EMG1 |
| (<<) CARD9 → EMG1 |
| (<<) CAV1 → EMG1 |
| (<<) CSTB → EMG1 |
| (<<) CXCR7 → EMG1 |
| (<<) CYR61 → EMG1 |
| (<<) DAB2 → EMG1 |
| (<<) DDX21 → EMG1 |
| (<<) ELK3 → EMG1 |
| (<<) GAPDH → EMG1 |
| (<<) KRAS → EMG1 |
| (<<) LRRC8C → EMG1 |
| (<<) MAP1B → EMG1 |
| (<<) MMP2 → EMG1 |
| (<<) MST1R → EMG1 |
| (<<) MYL6B → EMG1 |
| (<<) MYLK → EMG1 |
| (<<) NEDD4 → EMG1 |
| (<<) PDRG1 → EMG1 |
| (<<) PRR7 → EMG1 |
| (<<) SLC20A1 → EMG1 |
| (<<) SPRR1A → EMG1 |
| (<<) THBS1 → EMG1 |
| (<<) TIMM13 → EMG1 |
| (<<) TNFRSF1A → EMG1 |
| (<<) TNXB → EMG1 |
| Downstream (Children) |
|---|
| EMG1 → ANKRD57 (>>) |
| EMG1 → CNFN (>>) |
| EMG1 → EPHB6 (>>) |
| EMG1 → IDI1 (>>) |
| EMG1 → MAP2K3 (>>) |
| EMG1 → PLCB4 (>>) |
| EMG1 → SDCBP2 (>>) |
| EMG1 → STYK1 (>>) |
| EMG1 → SULT4A1 (>>) |
| EMG1 → TFPI2 (>>) |
